 clinical and anatomical
outcomes of RFA of symptomatic small-diameter
GSVs.122 RFA of symptomatic small diameter GSV
(<5 mm) provided comparable clinical outcomes (vein
closure and improved VCSS at 3 months) and the study
suggested that patients with GSV size <5 mm beneﬁt
from RFA.122 Bendix et al123 reviewed the Vascular
Quality Initiative VV Registry and divided